Hemo Organic Ltd (HEMORGANIC) — shareholding pattern, promoter holding, financials and share price
About Hemo Organic Ltd (HEMORGANIC)
Hemo Organic Ltd operates in the Trading & Distributors industry, within the Services sector. It trades on the NSE as HEMORGANIC and on the BSE under scrip code 524590. Its ISIN is INE422G01015.
Incorporated in 1992, Hemo Organic Ltd is in the business of trading & distribution of Rice and Textiles.
Hemo Organic Ltd, formerly known as Dinesh Allorga Limited, produces and sells white coal, ayurvedic medicines, and chemicals in India.
The company plans a strategic shift by entering the chemical manufacturing space with a new project near Khambhat, Gujarat.
Listed peers in Trading & Distributors: Sirohia & Sons Ltd, Shiva Suitings Ltd, Devine Impex Ltd, IGC Industries Ltd, Risa International Ltd, Nyssa Corporation Ltd.
Valuation & Returns
- Industry P/E
- 21.24x
- Book value / share
- ₹-2.7
- ROE
- -585.48%
- ROCE
- -17.34%
- ROA
- -17.71%
- Debt / equity
- 20.62x
- Dividend yield
- 0%
- EBITDA margin
- -53.76%
- 52-week range
- ₹8.08 – ₹22.51
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Hemo Organic Ltd (HEMORGANIC) reported revenue of ₹0.93 crore, net profit of ₹-0.78 crore and earnings per share of ₹-2.25. That compares with revenue of ₹2.41 crore and net profit of ₹0.16 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Jun 2026, net profit ₹-0.07 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 0.01 | 0 | 0.02 | 2.41 | 0.93 |
| Net profit (₹ cr) | -0.06 | -0.05 | -0.26 | 0.16 | -0.78 |
| EPS (₹) | -0.17 | -0.14 | -0.75 | 0.46 | -2.25 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 40.81% | 54.17% | 607.06% | - |
| Profit growth | - | - | - | 161.54% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 16.85% of Hemo Organic Ltd (HEMORGANIC) (unchanged from the previous quarter). Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2004.
Largest disclosed public shareholders in Jun 2026: MITALBEN RUPESHBHAI DESAI 3.49%, RUPESH RAMANLAL DESAI 3.49%, MANSUKHLAL CHHOTALAL SHAH 2.51%, RUCHIRA GOYAL 2.11%, RAJPUT VISHAL 1.78%, SAGAR SHETH 1.78%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 16.85% | - | - | - | 83.15% |
| Mar 2026 | 16.85% | - | - | - | 83.15% |
| Dec 2025 | 16.85% | - | - | - | 83.15% |
| Sep 2025 | 16.85% | - | - | - | 83.15% |
| Jun 2025 | 16.85% | - | - | - | 83.15% |
| Mar 2025 | 16.85% | - | - | - | 83.15% |
| Dec 2024 | 16.85% | - | - | - | 83.15% |
| Sep 2024 | 16.85% | - | - | - | 83.15% |